Cardiology Self‐Assessment Program (CardSAP) Book 1: Critical Care Cardiology (Cert # L209203)

ACPE Numbers: Various – see listing below
Pre‐sale Date: 04/15/2020
Content Release Date: 05/15/2020
Product sale end date: 11/16/2020
Activity Type: Application‐based
CE Credits: 21.5 hours (BPS and ACPE)
Activity Fee: $75 (ASHP member); $110 (non‐member)

Accreditation for Pharmacists

The American College of Clinical Pharmacy and American Society of Health‐System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.

Target Audience

The target audience for CardSAP 2020 Book 1 (Critical Care Cardiology) is board‐certified cardiology pharmacy specialists caring for patients with or at risk of cardiovascular disease.

Activity Overview

This course is intended for board-certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). The course consists of 4 learning modules (see table below) and provides up to TBD hours of continuing pharmacy education and/or recertification credit.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this course, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well‐established standards of practice in the specialty practice.

These activities are part of the ACCP and ASHP professional development program for BCCP recertification approved by the BPS

Recertification Credit*

Board-certified pharmacists are eligible to receive up to TBD hours of recertification credit for completing this course. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Learning Activity

ACPE Number

Credit

Hours

*Assessment

Pass Point

CardSAP 2020 Book 1: Critical Care Cardiology I

0217-9999-20-014-H01-P

5.5

73%

CardSAP 2020 Book 1: Critical Care Cardiology II

0217-9999-20-015-H01-P

5.0

66%

CardSAP 2020 Book 1: Critical Care Cardiology III

0217-9999-20-016-H01-P

5.0

63%

CardSAP 2020 Book 1: Critical Care Cardiology IV

0217-9999-20-017-H01-P

6.0

75%

 

Learning Objectives 

CardSAP 2020 Book 1: Critical Care Cardiology I
ACPE Number: 0217-9999-20-014-H01-P

  • Develop a patient‐specific therapeutic plan for antithrombotic therapy before coronary artery bypass grafting surgery
  • Evaluate critical medications for initiation or discontinuation before coronary artery bypass grafting surgery
  • Justify the importance of glycemic control during and immediately after coronary artery bypass grafting surgery
  • Developapatient‐specific therapeutic plan for rectifying hemodynamic instability after coronary artery bypass graftin surgery
  • Design a pharmacotherapy plan for the secondary prevention of ischemic events after coronary artery bypass grafting surgery
  • Evaluate patients for the pathophysiology of valvular heart disease.
  • Design evidence‐based management plans for perioperative hemodynamics, dysrhythmias, and vasoplegia in patients with valvular heart disease.
  • Design patient‐specific evidence‐based antithrombotic regimens for patients with valvular heart disease.
  • Evaluate patients undergoing valve replacement surgery for the unique management considerations of infective endocarditis.

CardSAP 2020 Book 1: Critical Care Cardiology II
ACPE Number: 0217-9999-20-015-H01-P

  • Develop a therapeutic plan using high‐dose insulin/euglycemia in the management of patients with beta‐blocker or calcium channel blocker toxicity.
  • Evaluate the role of intravenous lipid emulsion in the management of patients with beta‐blocker or calcium channel blocker toxicity.
  • Justify the use of additional therapies in the management of patients with beta‐blocker or calcium channel blocker toxicity.
  • Design a therapeutic plan for patients presenting with chronic digoxin toxicity.
  • Assess for the role of naloxone in clonidine toxicity.
  • Apply knowledge pharmacotherapy principles as well as pertinent clinical findings, and laboratory values to assist with the identification of medication-related causes of various cardiovascular disease states.
  • Distinguish between the various etiologies, time of onset, dose, and reversibility of medication-related cardiovascular diseases.
  • Evaluate the contribution of various medications to the development of select cardiovascular diseases.

CardSAP 2020 Book 1: Critical Care Cardiology III
ACPE Number: 0217-9999-20-016-H01-P

  • Evaluate differences between the various etiologies of cardiogenic shock.
  • Analyzepertinentlaboratoryvaluesandhemodynamicparameterstodistinguishthedifferent classifications of cardiogenic shock and outcomes.
  • Design a therapeutic regimen based on patient‐specific parameters and cardiogenic shock classification.
  • Distinguish the differences between the various types of temporary mechanical circulatory support.
  • Develop optimal pharmacotherapy in patients awaiting heart transplant (HT).
  • Design an effective induction immunosuppression regimen for patients undergoing HT.
  • DeviseanoptimalpharmacotherapeuticregimenfortheintraoperativemanagementofHT, including preservation solution and anesthesia induction.
  • Evaluate the risk factors, pathophysiology, and management of patients with primary graft dysfunction.
  • Design a post‐HT pharmacotherapeutic strategy that encompasses all aspects of postoperative care.

CardSAP 2020 Book 1: Critical Care Cardiology IV
ACPE Number: 0217-9999-20-017-H01-P

  • Analyze the role of advanced life support techniques, adjunctive care, and medication timing during cardiopulmonary resuscitation
  • Applyknowledgeofpharmacotherapyprinciplestoachievereturnofspontaneouscirculationinspecial circumstances relating to cardiac arrest.
  • Evaluatetherolesandresponsibilitiesofthepharmacistinensuringtheproperselectionand administration of medications in the peri‐cardiac arrest / medical emergency period
  • EvaluatethecommonriskfactorsforQTcprolongationprogressingtoTdPandapplydisease, drug, and patient information to primary and secondary prevention strategies.
  • Design an empiric antimicrobial regimen, as well as an antimicrobial regimen based on culture results, patients’ valve type, susceptibilities, drug‐disease interactions, and the patients’ allergy history for a patient diagnosed with infective endocarditis.
  • Developapharmacotherapytreatmentplanforthemanagementofacuteandrecurrentidiopathic pericarditis, including dosing, tapering, monitoring, and duration of therapy.
  • Design an individualized treatment plan for a patient diagnosed with myocarditis.
  • Develop a plan for administering medications to patients without intravenous access.
  • Assess the key elements for successful intranasal drug delivery
  • Delineatetheroleandplaceintherapyofintranasallyadministeredproceduralsedationagentspriorto emergent cardiovascular procedures
  • Evaluate the benefits and risks of the intraosseous route of administration for cardiovascular emergencies

Planners, Presenters, and Reviewers

Professor, Pharmacy Practice
College of Pharmacy
Western University of Health Sciences
Clinical Pharmacy Specialist, Cardiology
VA Greater Los Angeles Healthcare System
Los Angeles, California
Professor of Pharmacy Research Professor of Medicine
Executive Vice Chair, Division of Pharmacotherapy and Experimental Therapeutics
UNC Eshelman School of Pharmacy
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Professor and Chair of Pharmacy Practice
Department of Pharmacy Practice MCPHS University
Clinical Pharmacy Specialist Department of Pharmacy
Brigham and Women’s Hospital
Boston, Massachusetts
Emergency Medicine Clinical Pharmacy Specialist
Department of Pharmacy
Associate Professor
Department of Emergency Medicine
University of Rochester Medical Center
Rochester, New York
Clinical Pharmacist – Cardiothoracic Surgery Program Director, PGY2
Cardiology Residency Acute Care Pharmacy Services
University of Kentucky
Assistant Adjunct Professor
Department of Pharmacy Practice and Science
University of Kentucky College of Pharmacy
Lexington, Kentucky
Clinical Pharmacy Specialist, Cardiac/Cardiothoracic Surgery Intensive Care
Department of Pharmacy
North Kansas City Hospital North
Kansas City, Missouri
Clinical Pharmacy Manager, Cardiothoracic Intensive Care
Department of Pharmacy
New York-Presbyterian/Columbia University Irving Medical Center
New York, New York
Associate Professor of Pharmacy
Clinical Pharmacist, Heart Transplant and LVAD Team
New York-Presbyterian/Columbia University Irving Medical Center
New York, New York
Clinical Pharmacy Coordinator
Department of Pharmacy
Buffalo General Medical Center
Buffalo, New York
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Roper St. Francis Healthcare
Charleston, South Carolina
Clinical Pharmacy Coordinator – Cardiology and Critical Care
Department of Pharmacy
Abbott Northwestern Hospital, part of Allina Health
Minneapolis, Minnesota
Clinical Pharmacy Specialist, Emergency Medicine/Neurotrauma Critical Care
PGY1 Residency Coordinator Department of Pharmacy
North Kansas City Hospital North
Kansas City, Missouri
Specialty Practice Pharmacist
Department of Pharmacy
The Ohio State University Wexner Medical Center
Columbus, Ohio
Critical Care Pharmacist – Cardiothoracic Surgery Program Director, PGY2
Critical Care Residency Acute Care Pharmacy Services
University of Kentucky
Assistant Adjunct Professor
Department of Pharmacy Practice and Science
University of Kentucky College of Pharmacy
Lexington, Kentucky
Specialty Practice Pharmacist – Cardiology
Department of Pharmacy
The Ohio State University Wexner Medical Center
Columbus, Ohio
Toxicology Clinical Pharmacy Specialist
Department of Pharmacy
Assistant Professor
Department of Emergency Medicine
University of Rochester Medical Center
Rochester, New York
Assistant Professor
Department of Pharmacy: Clinical and Administrative Science
University of Oklahoma
College of Pharmacy
Oklahoma City, Oklahoma
Pharmacy Clinical Specialist – Cardiology
Department of Pharmacy
Medical University of South Carolina
Charleston, South Carolina
Clinical Pharmacy Coordinator
Department of Pharmacy
Kaleida Health
Buffalo, New York
Consultant Clinical Pharmacist, Adult Cardiology
Pharmacy Services Administration
King Fahad Medical City
Riyadh, Saudi Arabia
Jennifer L. Cole, Pharm.D., FCCP, BCPS, BCCCP
Clinical Pharmacy Specialist
Department of Pharmacy
Veterans Healthcare System of the Ozarks
Fayetteville, Arkansas
Megan A. Corrigan, Pharm.D., MPH, BCPS
Director of Pharmacy Services
Department of Pharmacy
Advocate Good Samaritan Hospital
Downers Grove, Illinois
Ilya M. Danelich, Pharm.D., BCPS, BCCP
Clinical Coordinator
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
Brianne Dunn, Pharm.D.
Associate Dean, Outcomes Assessment and Accreditation
Associate Professor
Clinical Pharmacy and Outcomes Sciences
University of South Carolina College of Pharmacy
Columbia, South Carolina
Brittany Florczykowski, Pharm.D., BCPS-AQ Cardiology
Clinical Pharmacist Specialist – Cardiology
Department of Pharmacy
UPMC Pinnacle
Harrisburg, Pennsylvania
Katie M. Greenlee, Pharm.D., BCPS-AQ Cardiology, BCCP
Cardiology Clinical Coordinator Cardiology Clinical Specialist
PGY-2 Cardiology Residency Program Director
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio
Michelle Lew, Pharm.D., BCPS, BCCP
Clinical Pharmacist
Department of Pharmacy
Scripps Memorial Hospital – La Jolla
La Jolla, California
Rhynn Malloy, Pharm.D., BCPS, BCCP
Clinical Pharmacy Specialist
Departments of Pharmacy, Cardiac Surgery, and Cardiology
Brigham and Women’s Hospital
Boston, Massachusetts
Mary Mekheil, Pharm.D., BCPS
Clinical Pharmacist
Break Through Care Center
DuPage Medical Group
Wheaton, Illinois
Sharon K. Milfred-LaForest, Pharm.D., FCCP, BCPS
Clinical Pharmacy Specialist, Cardiology and Organ Transplantation
Pharmacy Department
VA Northeast Ohio Health System
Cleveland, Ohio
Asmaa Kamal Mohammed, M.Sc., BCPS
Clinical Pharmacist
Department of Pharmacy
Royal Commission Medical Center
Yanbu al Synaia City, Saudi Arabia, Clinical Pharmacist
Department of Pharmacy
National Liver Institute
Menoufia, Egypt
Mikayla Muzzey, Pharm.D., MBA, BCPS
Clinical Pharmacist
Pharmacy Department
North Kansas City Hospital
North Kansas City, Missouri
Jared W. Netley, Pharm.D., MPA, BCPS, BCCCP
Clinical Pharmacist
Acute Care – Department of Pharmaceutical Care
University of Iowa Healthcare
Iowa City, Iowa
Phillip Owen, Pharm.D., BCPS
Cardiothoracic Unit Clinical Pharmacy Specialist
Department of Pharmacy
University of North Carolina Medical Center
Chapel Hill, North Carolina
Lisa Peters, Pharm.D., BCPS
Clinical Specialist Pharmacist, Advanced Heart Failure and Heart Transplant
Department of Pharmacy
MedStar Washington Hospital Center
Washington, D.C.
Christina Ruggia-Check, Pharm.D., BCPS, BCCP, AACC
Clinical Pharmacy Specialist – Cardiovascular Surgery/Heart Transplant
Department of Pharmacy
Temple University Hospital
Philadelphia, Pennsylvania
Harleen Singh, Pharm.D., BCPS-AQ Cardiology, BCACP
Clinical Associate Professor
Department of Pharmacy Practice
Oregon State University
Portland, Oregon
Kevin M. Sowinski, Pharm.D., FCCP
Professor of Pharmacy Practice
Department of Pharmacy Practice
Purdue University College of Pharmacy
West Lafayette and Indianapolis, Indiana Adjunct Professor of Medicine
Division of Clinical Pharmacology
Department of Medicine
Indiana University School of Medicine
Indianapolis, Indiana
Dustin Spencer, Pharm.D., MBA, BCPS, BCCP
Clinical Director, Cardiopulmonary and Critical Care
Cardinal Health
Martinsville, Indiana
Alan Tan, Pharm.D., BCPS
Clinical Pharmacist – General Medicine and Anticoagulation Health Sciences
Assistant Clinical Professor of Pharmacy
Department of Clinical Pharmacy
University of California San Francisco Medical Center
San Francisco, California
Rebecca JC Tran, Pharm.D., BCPS, BCACP, BCCP, CLS
Associate Professor
KGI School of Pharmacy and Health Sciences
Claremont, California
Kyle A. Weant, Pharm.D., FCCP, BCPS, BCCCP
Emergency Medicine
Clinical Pharmacy Specialist Residency Program Director, PGY2
Emergency Medicine
Department of Pharmacy Services
Affiliate Assistant Professor
College of Pharmacy
Medical University of South Carolina
Charleston, South Carolina
Kacy Whyte, Pharm.D., BCPS, BCCP
Clinical/Staff Pharmacist IV
Department of Pharmacy
Vidant Medical Center
Greenville, North Carolina
Assistant Professor of Clinical Education
Eshelman School of Pharmacy
University of North Carolina
Chapel Hill, North Carolina
Lianjie Xiong, Pharm.D., BCPS, BCCP
Emergency Medicine Clinical Pharmacist
Department of Pharmacy
Sutter Health memorial Medical Center
Modesto, California

The American College of Clinical Pharmacy and the authors thank the following individuals for their careful review of the Critical Care Cardiology I chapters:

Lynn Kassel, Pharm.D., BCPS
Associate Professor of Clinical Sciences
Department of Clinical Sciences
Drake University College of Pharmacy & Health Sciences
Des Moines, Iowa
Acute Care Pharmacist
MercyOne West Des Moines Hospital West
Des Moines, Iowa
Eric W. Mueller, Pharm.D., FCCM, FCCP
Assistant Director, Clinical Services and Research
Clinical Pharmacy Specialist, Critical Care
UC Health-University of Cincinnati Medical Center
Adjunct Associate Professor of Pharmacy Practice and Administrative Sciences
James L. Winkle College of Pharmacy
University of Cincinnati
Cincinnati, Ohio


The American College of Clinical Pharmacy and the authors thank the following individuals for their careful review of the Critical Care Cardiology II chapters:

Anne L. Hume, Pharm.D., FCCP, BCPS
Professor of Pharmacy
Department of Pharmacy Practice
University of Rhode Island
Kingston, Rhode Island
Adjunct Professor of Family Medicine
Alpert School of Medicine at Brown University
Providence, Rhode Island
Emilie L. Karpiuk, Pharm.D., BCPS
Oncology Pharmacist
Department of Pharmacy
Froedtert Hospital
Milwaukee, Wisconsin


The American College of Clinical Pharmacy and the authors thank the following individuals for their careful review of the Critical Care Cardiology III chapters:

Judy Cheng, Pharm.D., MPH, FCCP, BCPS-AQ Cardiology
Professor and Chair of Pharmacy Practice
Department of Pharmacy Practice
MCPHS University
Clinical Pharmacy Specialist
Department of Pharmacy
Brigham and Women’s Hospital
Boston, Massachusetts
Lisa C. Hutchison, Pharm.D., MPH, FCCP, BCPS, BCGP
Professor
Pharmacy Practice
University of Arkansas for Medical Sciences
Little Rock, Arkansas


The American College of Clinical Pharmacy and the authors thank the following individuals for their careful review of the Critical Care Cardiology IV features:

Joseph S. Bubalo, Pharm.D., BCPS, BCOP
Oncology Clinical Pharmacy Specialist
Assistant Professor of Medicine
Oregon Health and Science University Hospital and Clinics
Portland, Oregon
Judy Cheng, Pharm.D., MPH, FCCP, BCPS-AQ Cardiology
Professor and Chair of Pharmacy Practice
Department of Pharmacy Practice
MCPHS University
Clinical Pharmacy Specialist
Department of Pharmacy
Brigham and Women’s Hospital
Boston, Massachusetts
Jeffrey T. Sherer, Pharm.D., MPH, BCPS, BCGP
Clinical Professor
Department of Pharmacy Practice and Translational Research
University of Houston
College of Pharmacy
Houston, Texas

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, the American Society of Health-System Pharmacists (ASHP) and the American College of Clinical Pharmacy (ACCP) require that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ACCP and ASHP education activities are qualified and selected by ACCP and ASHP and required to disclose any relevant financial relationships with commercial interests. ACCP and ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Consultancies: Nicholas Schwier: Consultancies (Biomedical Insights, Inc.)
  • Stock Ownership: Brittany Florczykowski (Pfizer)
  • Honoraria: Douglas Jennings: Honoraria (Novartis Pharmaceuticals)
  • All other planners, presenters, reviewers, ASHP and ACCP staff and others with an opportunity to control content report no financial relationships relevant to this activity.

Methods and CE Requirements

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

System Technical Requirements

Learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development

These activities were developed by ACCP and ASHP.